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Abstract 
PURPOSE:  The purpose of this project was to measure adherence rates to the current 
alcohol use screening process, and identification of correlations of alcohol use and 
outcomes in patients admitted to Norton Hospital, via the emergency department.   
METHODS:  The study design is a retrospective descriptive evaluation, of adherence to 
the current alcohol use screening process, and associations among age, gender, ethnicity, 
length of stay, number of ICU days, restraint use days, level of care at admission (ICU, 
TCU, LLM/tele, MS), incidence of AWS/DTs, and activation of the CIWA protocol 
among the adult inpatient population of Norton Hospital’s downtown campus, admitted 
via the emergency department (ED), for greater than 24 hours, between April 2016 and 
April 2017.  The sample consisted of 300 randomly selected patient charts, using the 
inclusion criteria. 
RESULTS:  It was found that overall screening adherence for alcohol use on patients 
admitted from the emergency room was nearly 100%.  Among the study population 
26.3% screened positive, 4.3% had the specific diagnosis of alcohol withdrawal 
syndrome, 4.7% were treated with CIWA protocol.  Those who screened positive were 
more likely to be male, with a mean age of 49.8 years.  No statistical differences in 
ethnicity, level of care at admission, restraint use, mortality, number of ICU days, and 
length of stay were found within the study sample population, between those who 
screened positive or negative for alcohol use at admission.   
CONCLUSION: Further research needs to be done to better understand associations 
between alcohol use screening and ethnicity, level of care at admission, restraint use, 
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length of stay, number of ICU days and mortality in the overall population at Norton 
Hospital’s downtown campus.  Retrospective review revealed that there was a high level 
of adherence to the alcohol use screening process by the health care staff.  The screening 
process for alcohol use at admission is well documented within those admitted via the 
emergency department.   
 
 
ASSESSMENT OF ALCOHOL WITHDRAWAL SYNDROME  1 
Assessment of Alcohol Withdrawal Syndrome Incidence and Identification of Other Correlating 
Risk Factors in Patients Admitted Through the Emergency Department 
Introduction 
With alcohol and substance abuse problems continuing to rise rapidly throughout our 
nation, we are in need of a way to ensure proper identification and treatment of alcohol 
withdrawal syndrome in persons who present to the emergency department, and undergo an 
abrupt cessation of alcohol consumption due to an acute illness, and hospitalization.   This study 
is designed to determine if there was adherence to an established alcohol use screening process 
during the time frame, ensuring that those who are at risk for the development of alcohol 
withdrawal syndrome are being treated with the Clinical Institute Withdrawal Assessment 
(CIWA) protocol, and to determine correlating risk factors and demographics.  This study was 
designed with alignment of Neuman’s Systems Model nursing theory. Treating the patient as a 
fluid and dynamic being responding to their own personal environment leading to sickness and 
establishing health, using primary, secondary and tertiary care interventions.  Focusing on the 
patient as a whole, with multidimensional, layers of well-being: physiological, physiochemical, 
psychological, sociocultural and spiritual (Petiprin, 2016).    
Background 
As the problem with alcohol abuse and other substances continues to grow exponentially 
throughout our nation, and in particular in the state of Kentucky, we have seen a steady rise of 
alcohol withdrawal syndrome (AWS) incidence within the general hospital inpatient population.  
Approximately 9% of the adults in the United States meet the criteria for alcohol abuse (Burns, 
2015).  Within the general inpatient population alcohol withdrawal syndrome (AWS) can present 
in nearly 30% of patients; if left untreated AWS has a 15% mortality rate (Ungur, Neuner, John, 
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Wernecke, & Spies, 2013).  With early recognition and treatment, however, that mortality rate 
falls dramatically to 2% (Ungur et al., 2013).   
At the downtown campus of the 379 bed Norton Hospital in Louisville, KY, there were 
16,768 inpatient admissions in 2015 (US News Health Care Report, 2016). Based on the 30% 
incidence of AWS in the general inpatient population, this could have left 5,030 patients at risk, 
or 113 patients on any given day for the development of alcohol related complications that year.  
By ensuring that patients are screened for alcohol use at the time of hospital admission, a 
primary healthcare intervention, we have the opportunity to identify patients at risk for AWS so 
that timely prevention and/or treatment, a secondary healthcare intervention, can occur.   
 The abrupt cessation of alcohol intake by alcohol dependent patients puts them at risk for 
withdrawal, and a variety of complications.  These include development of AWS, post-operative 
complications and infections, increased length of stay and death (Bard et al., 2006). All of which 
can upset the balance of the wellness continuum described by Neuman’s Systems Model.  This 
can also cause problems for the hospital itself. For example the staff can be at risk of burnout, 
due to stress from caring for confused and combative patients; also it can be difficult to 
determine whether a patient’s confusion is due to AWS or another diagnosis, leading to 
increased costs and unnecessary testing (Ungar et al., 2013).  In addition, the hospital is at risk 
for increased post-operative complication rates, increased length of stay, and increased mortality, 
all of which lead to increased costs, and decreased patient and provider satisfaction (Ungar et al., 
2013).  In 2016 alone, healthcare costs related to alcohol induced complications in the United 
States amounted to $21 billion (Trevejo-Nunez, Kolls, & De Wit, 2016).     
 Currently, the screening tool for alcohol use at Norton Hospital is a yes or no question 
asked during the admission assessment within the admission navigator in the electronic medical 
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record system EPIC.  This important screening tool is not linked to prompt the provider to 
initiate treatment if the patient screens positive. The current standard of care treatment for AWS 
at Norton Hospital is utilized with the Clinical Institute Withdrawal Assessment (CIWA).  This 
protocol is a thorough nursing assessment done by the bedside nurse, using severity of ten 
symptoms of withdrawal, each tied to a number based upon level of severity.  These ten numbers 
are then added together for an overall composite score.  The composite score is then referenced 
for the appropriate treatment and frequency of reassessment (Appendix B).   If the alcohol use 
screening is left undocumented it leaves potentially hundreds of patients at risk for untreated 
AWS, and preventable healthcare dollars wasted.  
 The evidence shows that treatment preventing AWS at the earliest possible juncture, with 
a protocol for symptom triggered management such as the CIWA protocol, produces the best 
outcomes (Rubinsky et al., 2013; Melson, Kane, Mooney & McWilliams, 2014). These outcomes 
include a decrease in the development of AWS and Delirium Tremens (DTs), as well as 
decreases in use of restraints, a need for intensive care unit level of care, length of stay, risk of 
infections (sepsis, pneumonia, and surgical site), and complications from organ dysfunction 
(Melson, et al., 2014; Ungur, et al., 2013).  
By screening all patients for alcohol use at admission via the emergency department, 
(where a large portion of the inpatient admissions occur at Norton Hospital’s downtown 
campus), and ensuring adherence to the documentation of the current method in the admission 
navigator under alcohol use screening, we can capture a larger percentage of patients who will 
qualify for treatment, and monitor for complications of AWS.  In turn reducing alcohol use 
related complications and improvement of outcomes such as length of stay, utilization of higher 
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levels of care, use of restraints, and mortality.  As improvement in these things can reduce health 
care cost and increase patient satisfaction.  
Purpose 
The purpose of this project was to measure adherence rates to the current alcohol use 
screening process and identify outcomes (length of hospital stay, number of ICU days, restraint 
use, level of care at admission, and mortality), of patients admitted to Norton Hospital.  The 
adherence to the current alcohol screening process was reviewed via retrospective chart review.  
The specific aims of this project were: 
1. Measure adherence rate to the current alcohol use screening process, on all 
adults (those greater than 18 years of age), admitted as inpatients from the 
emergency department (ED), for greater than 24 hours between April 2016 
and April 2017.  
2. Identify subject demographics (medical record number, age, ethnicity, and 
gender), length of stay, number of ICU days, restraint use days, mortality, 
level of care at admission (ICU, Telemetry Care [TCU], Monitored Medical-
Surgical [LLM/tele] or Non-monitored medical surgical [MS]), incidence of 
AWS/DTs, and activation of the CIWA protocol in all adult patients admitted 
through the ED, for greater than 24 hours between April 2016 and April 2017.   
3. Perform in-group comparisons of subject demographics (age, ethnicity, 
gender), length of stay, number of ICU days, restraint use days, mortality, 
level of care at admission (ICU, TCU, LLM/tele, or MS), incidence of 
AWS/DTs, and activation of the CIWA protocol, among adult patients who 
screened positive for alcohol use, patients who screened negative for alcohol 
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use, and those patients who were not screened for alcohol use upon admission 
from the ED for greater than 24 hours, between April 2016 and April 2017.   
Methods 
This study was a single-center, retrospective, descriptive evaluation of adherence to the 
current alcohol use screening process, and the associations between age, gender, ethnicity, length 
of stay, number of ICU days, mortality, level of care at admission, incidence of AWS/DTs, and 
the activation of the CIWA protocol, among the adult inpatient population of Norton Hospital 
downtown campus, admitted via the ED.   
Setting 
Norton Hospital is one of five main hospitals of the Norton Healthcare System, and is the 
focus of this study.  Norton Hospital’s downtown campus is a general medical surgical hospital, 
with 379 inpatient beds, located in the urban, downtown area of Louisville, KY (US News Health 
Report, 2016).  It serves a large population from Jefferson County and many of the outlying, 
rural areas.  This site was selected for use in this study as it provides care to a wide range of 
patients, and has a highly utilized emergency room, from which the patients were selected.   
Sample  
The primary population for this study consisted of adult inpatients admitted through the ED 
for greater than 24 hours between April 2016 and April 2017 at Norton Hospital’s downtown 
campus.  From this primary population, 300 patients were randomly selected for the study.  
To meet inclusion criteria for this study, subjects had to be adults, aged greater than 18 years 
and, admitted as inpatients via the ED, for greater than 24 hours to Norton Hospital’s downtown 
campus between April 2016 and April 2017.  
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Because AWS/DTs occur mostly in the adult population, minors were excluded, from this 
study.  
Data Collection 
Prior to the collection of data, approval was obtained from the University of Kentucky 
Institutional Review Board (IRB) and the Norton Healthcare Office of Research and 
Administration (NHORA).  This study was conducted as a retrospective chart review.  The 
research office of Norton Healthcare randomly selected patient charts for the study from the 
Norton Hospital electronic patient database and sent to the primary investigator.  During data 
collection, the patient charts were accessed using the patient medical record number, data for the 
study were collected, and transferred to an electronic spreadsheet, made by this primary 
investigator, using the patients de-identified unique study ID, and the demographic and outcome 
variables requested to be collected. The following demographic variables (age, ethnicity, and 
gender), and outcome variables (length of stay, number of ICU days, restraint use, restraint use 
days, mortality, incidence of AWS/DTs, level of care at admission, activation of the CIWA 
protocol, and alcohol use screening documentation) were reviewed.  
Data Analysis 
Descriptive statistics, including means, standard deviations, ranges, medians, and 
percentages were used to describe the patient demographic and outcome variables.  Only one 
individual was not screened for alcohol use, therefore group comparisons of study variables were 
based on those who screened positive versus negative for alcohol use.  Continuous variables 
were compared between those who screened positive, and those that screened negative for 
alcohol use, using the independent sample t-tests.  For categorical variables the chi-squared test 
of association, or the Fisher’s exact test was used.  The Mann-Whitney U-test was used to 
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compare groups on length of hospital stay, and number of ICU days outcomes, since the 
distributions were skewed.  All statistical analysis was done using SPSS version 24 and an alpha 
level of .05 was used for statistical significance throughout.   
Results 
Sample Characteristics 
For this study, 300 charts were reviewed from randomly selected patients’ charts meeting 
the inclusion criteria.  The mean age for the collective sample was 55.9 years old (SD=17.3), and 
over half (59.7%; see Table 1) were female.  The majority of the population was Caucasian 
(55.3%), followed by African-American (43.3%). The largest portion of admissions went to a 
TCU level of care (35.3%) and MS (35.3%), followed by ICU (16.7%).  The use of restraints 
among the sample was low (5.3%).  The median length of hospital stay in days was 5 days, (1-
214 days).  Among the 50 patients who were identified as having been in the ICU the median 
number of days in ICU was 3 days (1-32).  Mortality was high (16.0%) among the sample 
population.  Only 1 patient was identified as not being screened for alcohol use (eliminating it as 
a group for comparison within the study), a majority of the sample was screened negative for 
alcohol use (73.3%), followed by those who screened positive for alcohol use (26.3%).   
Alcohol Use Screening Adherence 
For the collective study sample the adherence rate to the alcohol use screening 
documentation was high, at 99.7%; finding that only one patient was not screened at admission.  
Approximately one quarter (26.3%) of screened patients yielded a positive result.   
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Patient Demographics 
The patient demographics collected during this study were age, ethnicity, and gender.  
There were no statistical differences found in ethnicity, or age, between those who screened 
positive and those who screened negative for alcohol use.   
  For gender, it was broken into male and female.  For the overall study population the 
majority of patients were female (59.7%).  For those who screened positive for alcohol use 
approximately a third were male (33.9%).  There was statistical significance (p=.016) that males 
were more likely to screen positive for alcohol use, as was concurrent with the literature.   
Correlations to outcomes 
The following outcome variables were collected in this study: level of care at admission, 
length of stay, number of ICU days, use of restraints and length of use, if there was a diagnosis 
of AWS/DTs, if the CIWA protocol for withdrawal treatment was activated, and mortality.  For 
the overall study population 50 patients (16.7%) were admitted to the ICU, 144 patients (48%) 
were admitted to the TCU, and 106 patients (35.3%) were admitted to the MS units.  For those 
who screened positive for alcohol use 16 (20.3%) went to the ICU, 29 (36.7%) went to the TCU, 
and 34 (43%) went to MS units.  For those who screened negative for alcohol use 34 (15.5%) 
went to the ICU, 115 (52.3%) went to the TCU, and 71 (32.3%) went to the MS units.  There 
was no statistically significant difference (p=.113) for the level of care at admission between 
those who screened positive and those who screened negative for alcohol use.   
The median length of stay (LOS) for the study population was five days, with a minimum 
of one day and the maximum of 214 days.  For those who screened positive for alcohol use the 
median LOS was four days, with a minimum of one day, and a maximum of 61 days.  For those 
that screened negative the median LOS was five days, with a minimum of one day, and a 
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maximum of 214 days.  Using the Mann-Whitney U test it was determined that there was no 
significant differences in the two groups (p=.975).   
The number of ICU days for the study population was a median of three days, with a 
minimum of one day, and a maximum of 32 days.  For patients who screened positive for alcohol 
use the number of ICU days was a median of two days, with a minimum of one day, and a 
maximum of 16 days.  For those who screened negative for alcohol use the median number of 
ICU days was three days, with a minimum of one day, and a maximum of 32 days.  No 
statistically significant differences were found between the two groups.   
Restraints were used in 16 patients, 5.3% out of the overall study population.  Of those 
who screened positive for alcohol use there were six patients (7.6%) who were placed in 
restraints, for a median of two days.  Restraints were used in 10 patients (4.5%), who screened 
negative for a median of two days.  There was no statistically significant difference in the use of 
restraints between the two groups (p=.380). 
There were 13 patients (4.3%) with an actual diagnosis of AWS or DTs, all of whom 
screened positive for alcohol use, and were treated with the CIWA protocol.  Only one patient 
who screened negative for alcohol use at admission, was found to actually need treatment for 
alcohol withdrawal and was treated with the CIWA protocol within the sample, making a total of 
14 patients (4.7%) treated for AWS within the study sample population.   
Mortality in the overall study population was shown to be 16.0% (48 patients).  Those 
who screened positive for alcohol use four patients (5.1%) were deceased at the end of the 
hospital admission.  For those that screened negative for alcohol use 44 patients (20.0%) were 
found to be deceased at the end of hospital admission.  There was a significant correlation 
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(p=.002) between screening negative for alcohol use and mortality, opposite of the current 
literature.  
Discussion 
This study sought to determine adherence rates for alcohol use screening documentation 
on patients admitted to Norton Hospital’s downtown campus via the emergency department.  In 
addition it sought to measure subject demographics (age, gender and ethnicity), and measure 
outcomes including hospital length of stay, number of ICU days, use of restraints and length of 
use, incidence of AWS/DTs, level of care at admission, incidence of activation of the CIWA 
protocol, and mortality, among the study population.  An in-group comparison between those 
who screened negative for alcohol use, those who screened positive for alcohol use and, those 
who were not screened, was done to determine any associations of outcomes to a particular 
group.  The results showed that only one person was not screened for alcohol use making that 
group obsolete for comparison.   
Alcohol Use Screening Documentation Adherence 
The rate of adherence to the alcohol use screening documentation within the admission 
history was 99.7%.  There is a selectable response of yes, no, or not asked, in which the nursing 
staff or care treatment team is able to document.  This result is very high, showing consistent 
adherence, with no need for a performance improvement intervention.  Further expansion of the 
study population to all methods of admission, not just those from the ED, may yield different 
results, and could be examined in another study.  Expansion into the primary care setting as well 
could help provide insight to the consistency across the entire healthcare continuum and Norton 
Healthcare system. 
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Alcohol Withdrawal Syndrome Incidence 
With adherence to the alcohol use screening at nearly 100%, the hospital was able to 
capture 79 patients (26.3%), within the study population who were at risk for developing 
AWS/DTs.  This aligns closely with the national average of nearly 30% of the inpatient 
population (Ungur et al., 2013).  In addition 14 patients (16.3%) were determined to need 
treatment for withdrawal symptoms using the CIWA protocol.   This shows that with high 
adherence to screening for alcohol use the treatment team is able to use that information to 
provide the earliest, and best care using the CIWA protocol when indicated, producing the best 
possible outcomes for patients (Rubinsky et al., 2013; Melson, et al., 2014). 
Patient Demographics 
Those patients in the study sample population who screened positive for alcohol use were 
statistically younger at 49.8 years (p< .001), compared to those that screened negative (58.2 
years) and the overall population (55.9 years).  This seems to be appropriate and expected, as 
younger people consume more alcohol, and more regularly, (Burns, 2015).   
There was also evidence that males are more likely to screen positive for alcohol use than 
females (p= .016), which is consistent with the literature reviewed, that males tend to participate 
in riskier behaviors (Ungar, et al., 2013).   
No relationship was found between ethnicity and results of the alcohol use screening in 
this study (p=.479).  All patients who screened positive for alcohol use were either Caucasian 
(55.7%) or African-American (44.3%) in this study. As alcohol misuse is found in all people 
regardless of ethnicity, this finding aligns with other research (Ungar, et al., 2013).   
In conclusion those patients who screened positive for alcohol use in this study were 
males of approximately 50 years of age, and nearly equally distributed among ethnicities.    
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Length of Stay/ICU days 
In this study it was surprisingly found that those who screened positive for alcohol use 
had a shorter length of stay, at four days, compared to five days for those who screened negative.  
Though not statistically significant, it is clinically significant and this difference may be due in 
part to the population’s method of admission (via the ED), and the patients’ other medical 
conditions and primary diagnoses.  Another factor that could have influenced the data was that 
all 13 patients identified for treatment with the CIWA protocol, screened positive for alcohol use 
and treated appropriately, potentially decreasing sequelae from withdrawal and potentiating a 
shorter length of stay.  Future studies could examine this more closely.   
There was found to be no significant difference between a patients’ positive or negative 
screening for alcohol use and the number of days they spent in the ICU.   For those who screened 
positive there was a median of two ICU days, and for those who screened negative there was a 
median of three ICU days.  This slight difference may be due to patients being treated with the 
CIWA protocol when withdrawal was identified, to reduce escalation of care or time needed in 
the ICU.  This too could be examined more closely in a future study.   
Restraint Use Incidence 
Although there was a slightly higher incidence of restraint use in those patients who 
screened positive for alcohol use (7.6%) compared to, those who screened negative (4.5%), there 
was no statistically significant difference (p= .550) between the two groups.  This could be due 
to a low incidence of restraint use within the overall group, with only 16 patients (5.3%) having 
been placed in restraints. Reasoning for placement of restraints could be examined in future 
studies to determine if it was due to sequelae of withdrawal, such as delirium or agitation.    
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Mortality 
Surprisingly, there was a 16% mortality rate among the overall study population, and an 
equally shocking finding of a significantly lower mortality rate among those who screened 
positive for alcohol use compared to the overall population and to those who screened negative 
for alcohol use (p= .002).  Those who screened positive for alcohol use had a 5.1% mortality 
rate, with only four patients found to be deceased at the end of the hospital admission.  Those 
who screened negative for alcohol use had a 20.0% mortality rate, with 44 patients found to be 
deceased at the end of the hospital admission.  There are several factors that may be skewing the 
data in this unexpected direction.  One factor may be the population itself, as most people 
admitted to the hospital from the ED often have more life-threatening diagnoses or substantial 
illnesses, than alcohol use or withdrawal.  Another factor that may have skewed the data is the 
high adherence rate to the alcohol use screening and use of treatment with the CIWA protocol, 
which could have decreased the severity of sequelae from withdrawal and reduced the incidence 
of life-threatening complications.   
Limitations 
There were several limitations identified in the design of this study.  The first one is the 
study’s population being limited to admissions from the ED.  Looking at only the ED could have 
affected the results of this study in multiple ways, such as the adherence to screening for alcohol 
use.  It is possible that this particular department is more stringent in documenting this portion of 
the admission history, compared to other departments within the hospital.  Mortality and length 
of stay, including number of ICU days could have been affected by only using admissions from 
the ED.  Many people who are seen, treated, and admitted by way of the ED have significant or 
life-threatening injuries or medical problems, leading to higher rates of death and length of stay, 
ASSESSMENT OF ALCOHOL WITHDRAWAL SYNDROME  14 
compared to other patients. Post-elective surgery patients, for example, have an expected length 
of stay and discharge plan.  Patients admitted from the ED may not have this.  
Another limitation of this study was, using only one of the Norton Healthcare hospitals 
that serve this community.  Different results may be obtained by using more than one site, as the 
other facilities serve patients with some of the same demographics.  Future research could 
compare between the facilities to ensure that adherence to the screening process for alcohol use 
and treatment with the CIWA protocol is similar across the Norton Healthcare system.   
Recommendations for Future Studies and Next Steps 
The results of this study suggest several opportunities for further research into screening 
for alcohol use at admission.   It may be helpful to expand the sample population to all methods 
of admission, not just via the ED.  This would allow a broader look at the population that Norton 
Hospital (downtown campus) serves.  This could be taken further to include the other Norton 
Healthcare facilities, including the primary and immediate care facilities, to ensure system wide 
consistency with documentation for alcohol use as well as treatment with the CIWA protocol for 
withdrawal, in the hospital setting.  Further investigation of the use of the CIWA protocol could 
also include the time frame of alcohol use screening at hospital admission, to the time of 
activation of the protocol.  This could assist with determining how closely these two variables 
are correlated.   
As well as determining that screening for alcohol use is not just being done within a 
hospital admission, and is being monitored and documented within the primary care arena as 
well.  Many of the patients seen as inpatients access care outside of the hospital itself.  The 
records of those patients that seek care within the Norton Healthcare system, either in the 
hospital, primary care or immediate care setting, are accessible to any provider that sees them 
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within the Norton Healthcare system.  Allowing ease of follow-up and ability for full review of 
all care provided.  As screening is a primary healthcare intervention it should also be done prior 
to a stressor such as a hospital admission.  
A more in depth investigation into some of the variables such as mortality, length of stay, 
number of ICU days, and restraint use may be helpful in determining a trend, and/or reasoning 
why some of the results of this study were not as expected.  For example, why there was lower 
mortality within the group that screened positive for alcohol use.  This could be done by 
collecting data regarding admitting diagnoses and past medical history to determine the co-
morbidity burden.  As well as socioeconomic characteristics, that may impact mortality. 
There may also be value in expanding this study to include screening for substance abuse 
to determine if there are correlations between alcohol use and substance abuse, and if we are 
treating this population with the best evidence based care as well.  This is especially relevant as 
the number of opioid related deaths and complications continue to rise in this area of the country.  
Gathering this data as well could give us as healthcare providers a better insight to the full 
spectrum of the underlying problems our patients face.  To ensure that we are not just treating 
one problem such as alcohol withdrawal, when there are other problems that need to be 
addressed in addition, such as opioid misuse and withdrawal, that often complicate treatment 
plans.  This data can also help to determine the extent of the problems in this community and 
provide information about the demands of the community, so that we can help those in need, and 
find out how the Norton Healthcare system can provide these services.  
Conclusion 
The aim of this study was to measure adherence rates to the current alcohol use screening 
process and identify outcomes of patients admitted to Norton Hospital via the emergency 
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department.  In addition, to identify subject demographics (age, ethnicity, and gender), length of 
stay, number of ICU days, incidence of restraint use and number of days used, mortality, 
incidence of AWS/DTs, and activation of the CIWA protocol.  
In-group comparisons of subject demographics (age, ethnicity, gender), length of stay, 
number of ICU days, restraint use days, mortality, level of care at admission (ICU, TCU, 
LLM/tele, or MS), incidence of AWS/DTs, and activation of the CIWA protocol, among adult 
patients who screened positive for alcohol use, patients who screened negative for alcohol use, 
and those patients who were not screened for alcohol use upon admission determined that those 
who will screen positive for alcohol use are males, with a median age of 49.8 years old.  It was 
also identified that the adherence rate for screening for alcohol use was nearly 100%, within the 
study’s sample population.  Surprisingly it was identified that those who screened positive for 
alcohol use had a lower mortality rate, and should be examined more in depth in the future.  As 
well as a more comprehensive dissection of the results regarding length of stay, number of ICU 
days, and the use of restraints, as none of these results were found to have statistically significant 
differences among those that screened negative and positive for alcohol use.   
This study has laid the ground work for future studies about alcohol use screening, and 
providing the best evidence-based care to the population served at Norton Hospital’s downtown 
campus.   
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Table 1. Descriptive summary of ED patients (N=300) 
Variable Mean (SD); median (range); n (%) 
Age 55.9 years (17.3) 
Gender 
   Male 
   Female 
 
121 (40.3%) 
179 (59.7%) 
Race/Ethnicity 
   White 
   African American 
   Other 
  
166 (55.3%) 
130 (43.3%) 
4 (1.3%) 
Level of care 
   ICU 
  TCU 
   MS 
 
50 (16.7%) 
144 (35.3%) 
106 (35.3%) 
Restraints 
   Yes 
   No 
 
16 (5.3%) 
284 (94.7%) 
Length of hospital stay in days 5 (1-214)  
Number of ICU days 3 (1-32) 
Mortality 
  Deceased 
   Alive 
 
48 (16.0%) 
252 (84.0%) 
Alcohol screening 
   Positive 
   Negative  
   Not screened 
 
79 (26.3%) 
220 (73.3%) 
1 (0.3%) 
Diagnosis of AWS 
Diagnosis of DTs 
13 (4.3%) 
1 (0.3%) 
CIWA protocol activated 
    Yes 
 
14 (4.7%) 
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Table 2. Associations between Demographic Variables, Patient Outcomes, and Alcohol Use Screening (n=299) 
 Screening positive 
(n=79) 
Mean (SD) or n (%) 
Screened negative 
(n=220) 
Mean (SD) or n (%) 
p 
Age 49.8 years (14.5) 58.2 years (17.8) <.001 
Gender 
   Male 
   Female 
 
41 (33.9%) 
38 (28.3%) 
 
80 (66.1%) 
140 (78.7%) 
 
.016 
Race 
   White 
   African-American 
    Other 
 
44 (55.7%) 
35 (44.3%) 
0 (0) 
 
122 (55.5%) 
94 (42.7%) 
4 (1.8%) 
 
.479 
 
Level of Care 
    ICU 
    TCU 
    MS 
 
16 (20.3%) 
29(36.7%) 
34 (43.0% 
 
34 (15.5%) 
115 (52.3%) 
71 (32.3%) 
 
.113 
Restraints 
    Yes 
    No 
 
6 (7.6%) 
73 (92.4%) 
 
10 (4.5%) 
210 (95.5%) 
 
.302 
 
Length of Hospital Stay 
in Days 
4 (1-61) 5 (1-214)                 .975 
Number of ICU days 2 (1-16) 3 (1-32)                 .994 
Mortality 
    Deceased 
    Alive 
 
4 (5.1%) 
75 (94.9%) 
 
44 (20.0%) 
176 (80.0%) 
 
.002 
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Table 3:  Hospital Adherence to Alcohol Use Screening 
Variable Admission level 
of care ICU 
(n=50) 
Admission level 
of care TCU 
(n=144) 
Admission level 
of care MS 
(n=106) 
Hospital 
screening 
Adherence 
   
0-20%=0    
21-40%=1    
41-60%=2    
61-80%=3    
81-100%=4 X X X 
    
Actual % 100% 100% 99.1% 
 50/50 144/144 105/106 
    
    
Overall hospital 
adherence rate 
(not level of care 
separated) 
(n=300) 
   
% of screening 
done  
99.7% 
299/300 
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Appendix A Data Collection Tool for Patient Information 
 
 
Variable Patient 1A Patient 1B Patient 1C Patient 1D 
Age     
Actual age      
Sex     
Male=0     
Female=1     
Ethnicity     
White=1     
African-
American=2 
    
Other/unknown=3     
Alcohol use      
Yes=0     
No=1     
Not documented=2     
Length of Stay 
(days) 
    
Actual number of 
days 
    
CIWA protocol 
activated 
    
Yes=0     
No=1     
Number ICU days     
Actual # of days (if 
applicable) 
    
Restraints     
Yes=0     
No=1     
# of days used     
     
Diagnosis of AWS     
Yes=0     
No=1     
Diagnosis of DTs     
Yes=0     
No=1     
Mortality     
Deceased=0     
Alive=1     
     
     
Level of care at 
admission 
    
ICU=0     
TCU=1     
MMS=2     
MS=3     
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Appendix B 
Alcohol Withdrawal Assessment Scoring Guidelines (CIWA - Ar) 
 
 
 
 
 
Nausea/Vomiting - Rate on scale 0 - 7 
 
0 - None 
1 - Mild nausea with no vomiting 2 
3 
4 - Intermittent nausea 5 
6 
7 - Constant nausea and frequent dry heaves and vomiting 
Tremors - have patient extend arms & spread fingers. Rate on scale 0 - 7. 
0 - No tremor 
1 - Not visible, but can be felt fingertip to fingertip 2 
3 
4 - Moderate, with patient’s arms extended 5 
6 
7 - severe, even w/ arms not extended 
Anxiety - Rate on scale 0 - 
7 0 - no anxiety, patient at 
ease 1 - mildly anxious 
2 
3 
4 - moderately anxious or guarded, so anxiety is 
inferred 5 
 
          
     
Agitation - Rate on scale 0 
- 7 0 - normal activity 
1 - somewhat normal 
activity 2 
3 
4 - moderately fidgety and 
restless 5 
 
          Paroxysmal Sweats - Rate on Scale 0 - 7. 
0 - no sweats 
1- barely perceptible sweating, palms 
moist 2 
3 
4 - beads of sweat obvious on 
forehead 5 
 
    
Orientation and clouding of sensorium - Ask, “What day is 
this? Where are you? Who am I?” Rate scale 0 - 4 
0 - Oriented 
1 – cannot do serial additions or is uncertain about date 
2 - disoriented to date by no more than 2 
calendar days 3 - disoriented to date by more 
    
         Tactile disturbances - Ask, “Have you experienced any 
itching, pins & needles sensation, burning or numbness, 
or a feeling of bugs crawling on or under your skin?” 
0 - none 
1 - very mild itching, pins & needles, burning, or 
numbness 2 - mild itching, pins & needles, burning, 
or numbness 
3 - moderate itching, pins & needles, burning, or 
numbness 4 - moderate hallucinations 
    
    
    
 
Auditory Disturbances - Ask, “Are you more aware of 
sounds around you? Are they harsh? Do they startle you? 
Do you hear anything that disturbs you or that you know 
isn’t there?” 
0 - not present 
1 - Very mild harshness or ability to 
startle 2 - mild harshness or ability to 
startle 
3 - moderate harshness or ability to 
startle 4  moderate hallucinations 
    
    
    
 
Visual disturbances - Ask, “Does the light appear to be 
too bright? Is its color different than normal? Does it 
hurt your eyes? Are you seeing anything that disturbs 
you or that you know isn’t there?” 
0 - not present 
1 - very mild 
sensitivity 2 - mild 
sensitivity 
3 - moderate sensitivity 
4 - moderate 
hall cinations 5  se ere 
 
    
    
 
Headache - Ask, “Does your head feel different than 
usual? Does it feel like there is a band around your head?” 
Do not rate dizziness or lightheadedness. 
 
0 - not present 
1 - very mild 
2 - mild 
3 - moderate 
4 - moderately 
severe 5  severe 
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Procedure: 
1. Assess and rate each of the 10 criteria of the CIWA scale. Each criterion is rated on a scale from 0 to 7, except for “Orientation and clouding of sensorium” which is 
rated on scale 0 to 4. Add up the scores for all ten criteria. This is the total CIWA-Ar score for the patient at that time. Prophylactic medication should be started for any 
patient with a total CIWA-Ar score of 8 or greater (ie. start on withdrawal medication). If started on scheduled medication, additional PRN medication should be given 
for a total CIWA-Ar score of 15 or greater. 
2. Document vitals and CIWA-Ar assessment on the Withdrawal Assessment Sheet. Document administration of PRN medications on the assessment sheet as well. 
3. The CIWA-Ar scale is the most sensitive tool for assessment of the patient experiencing alcohol withdrawal. Nursing assessment is vitally important. Early intervention 
for CIWA-Ar score of 8 or greater provides the best means to prevent the progression of withdrawal. 
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Assessment Protocol 
a. Vitals, Assessment Now. 
b. If initial score ≥ 8 repeat q1h x 8 
hrs, then if stable q2h x 8 hrs, then 
if stable q4h. 
c. If initial score < 8, assess q4h x 72 
hrs. If score < 8 for 72 hrs, d/c 
assessment. If score ≥ 8 at any 
time, go to (b) above. 
d. If indicated, (see indications below) 
administer prn medications as 
ordered and record on MAR and 
below. 
Date             
Time             
Pulse             
RR             
O2 sat             
BP             
Assess and rate each of the following (CIWA-Ar Scale): Refer to reverse for detailed instructions in use of the CIWA-Ar 
scale. 
    
Nausea/vomiting (0 - 7) 
0 - none; 1 - mild nausea ,no vomiting; 4 - intermittent 
nausea; 7 - constant nausea , frequent dry heaves & 
vomiting. 
            
Tremors (0 - 7) 
0 - no tremor; 1 - not visible but can be felt; 4 - moderate 
w/ arms extended; 7 - severe, even w/ arms not extended. 
            
Anxiety (0 - 7) 
0 - none, at ease; 1 - mildly anxious; 4 - moderately 
anxious or guarded; 7 - equivalent to acute panic state 
            
Agitation (0 - 7) 
0 - normal activity; 1 - somewhat normal activity; 4 - 
moderately fidgety/restless; 7 - paces or constantly 
thrashes about 
            
Paroxysmal Sweats (0 - 7) 
0 - no sweats;  1 - barely  perceptible sweating,  palms 
moist; 4 - beads of sweat obvious on forehead; 7 - 
drenching sweat 
            
Orientation (0 - 4) 
0 - oriented; 1 - uncertain about date; 2 - disoriented to 
date by no more than 2 days; 3 - disoriented to date by > 
2 days; 
4 - disoriented to place and / or person 
            
Tactile Disturbances (0 - 7) 
0 - none; 1 - very mild itch, P&N, ,numbness; 2-mild 
itch, P&N, burning, numbness; 3 - moderate itch, P&N, 
burning ,numbness; 4 - moderate hallucinations; 5 - 
severe hallucinations; 
6 – extremely severe hallucinations; 7 - continuous 
hallucinations 
            
Auditory Disturbances (0 - 7) 
0 - not present; 1 - very mild harshness/ ability to startle; 
2 - mild harshness, ability to startle; 3 - moderate 
harshness, ability to startle; 4 - moderate hallucinations; 
5 severe hallucinations; 
6 - extremely severe hallucinations; 7 - 
continuous.hallucinations 
            
Visual Disturbances (0 - 7) 
0 - not present;    1 - very mild sensitivity; 2 - mild 
sensitivity; 
3 - moderate sensitivity; 4 - moderate hallucinations; 5 - 
severe hallucinations; 6 - extremely severe 
hallucinations; 7 - continuous hallucinations 
            
Headache (0 - 7) 
0 - not present; 1 - very mild; 2 - mild; 3 - moderate; 4 - 
moderately severe; 5 - severe; 6 - very severe; 7 - extremely 
severe 
            
Total CIWA-Ar score:             
PRN Med: (circle 
one) Diazepam
 Loraze
pam 
Dose given 
(mg): 
            
Route:             
Time of PRN medication 
administration: 
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Assessment of response (CIWA-Ar score 
30-60 
minutes after medication administered) 
            
RN Initials             
 
Scale for Scoring: 
Total Score = 
0 – 9: absent or minimal 
withdrawal 10 – 19: mild to 
moderate withdrawal more 
than 20: severe withdrawal 
Indications for PRN medication: 
a. Total CIWA-AR score 8 or higher if ordered PRN only (Symptom-triggered method). 
b. Total CIWA-Ar score 15 or higher if on Scheduled medication. (Scheduled + prn 
method) Consider transfer to ICU for any of the following: Total score above 35, q1h 
assess. x more than 8hrs required, more than 4 mg/hr lorazepam x 3hr or 20 mg/hr 
diazepam x 3hr required, or resp. distress. 
Patient Identification (Addressograph) 
Signature/ Title Initials Signature / Title Initials 
    
    
    
    
    
 
 
Alcohol Withdrawal Assessment Flowsheet (revised Nov 2003) 
